(Q37821048)

23 August 2017

1 reference

title

Rescuing neurons in prion disease (English)

1 reference

23 August 2017

0 references

Nicholas C Verity

1

1 reference

23 August 2017

Giovanna R Mallucci

series ordinal

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 January 2011

1 reference

23 August 2017

1 reference

23 August 2017

volume

433

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

19-29

1 reference

Molecular neurology of prion disease

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Molecular biology of prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Prion dementia without characteristic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Subclinical prion infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Natural and experimental prion diseases of humans and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Fatal familial insomnia: clinical and pathologic study of five new cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Transmission of fatal familial insomnia to laboratory animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

A systematic review of prion therapeutics in experimental models

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

No propagation of prions in mice devoid of PrP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Mice devoid of PrP are resistant to scrapie

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Normal host prion protein necessary for scrapie-induced neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Axonal prion protein is required for peripheral myelin maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Developmental expression of the prion protein gene in glial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Analysing hippocampal function in transgenic mice: an ethological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Burrowing into prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Early behavioural changes in scrapie-affected mice and the influence of dapsone

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Tau suppression in a neurodegenerative mouse model improves memory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Effective expression of small interfering RNA in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Silencing of human alpha-synuclein in vitro and in rat brain using lentiviral-mediated RNAi

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

RNAi therapeutics for CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Improved distribution of small molecules and viral vectors in the murine brain using a hollow fiber catheter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Staging of Alzheimer's disease-related neurofibrillary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Transmission and spreading of tauopathy in transgenic mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

The propagation of prion-like protein inclusions in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Prion protein and Abeta-related synaptic toxicity impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Memory impairment in transgenic Alzheimer mice requires cellular prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

The prion protein as a receptor for amyloid-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

Species-barrier-independent prion replication in apparently resistant species

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20101323

21 January 2018

Identifiers

DOI

10.1042/BJ20101323

1 reference

23 August 2017

1 reference